Credit Spreads Weather Recent Rise in U.S. Treasury Yields Relatively Well -- Market Talk
Dow Jones2026/10/14 05:270527 GMT - Credit spreads for investment-grade and high-yield corporate bonds have remained relatively stable despite recently surging U.S. Treasury yields, BondBloxx Investment Management's JoAnne Bianco says in a note. "The fact that credit spreads remain contained despite the significant selloff in long-dated U.S. Treasurys argues against this being a classic risk-off environment," the senior investment strategist says. Instead, the current environment is more of a term-premium and rates repricing event rather than a signal that corporate bond fundamentals are deteriorating, she says. "In other words, the markets are not pricing broad corporate credit problems. Most of the pain in fixed income has come from duration exposure, not spread widening," Bianco says. (emese.bartha@wsj.com)
(END) Dow Jones Newswires
October 14, 2026 01:27 ET (05:27 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts
Itaúsa Q3 2026 recurring net profit rises 25% to R$ 5.06 billion year-on-year
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
Crypto prices
More
